Jeff recently spoke with Pulitzer-prize winning journalist Kathleen Gallagher on her podcast “How Did You Do That?”, discussing his expansive career in life sciences and why he is committed to solving some of the world’s… Read more
Chicago is in the midst of a biotech influx, with expansive lab space planned for development. The recent growth can be largely attributed to a year focused on science and medical advancement due to the… Read more
Dr. Chavala is co-founder of CiRC Biosciences with Jeff Aronin, chairman and CEO of Paragon Biosciences Chicago, June 3, 2021—CiRC Biosciences, Inc., Co-Founder and Chief Scientific Officer Sai Chavala, M.D., has been awarded the 2021… Read more
Evozyne, a portfolio company of Paragon Biosciences, announced that a peer-reviewed publication in the journal Science demonstrates successful use of its world-class molecular engineering technology to create never-before-seen proteins with exceptionally advanced functionality. The Chicago-based… Read more
The latest edition of Insights Success magazine highlights the efforts of Jeff Aronin, Paragon Biosciences chairman and CEO, to build innovative life science companies that are developing solutions for both human disease and societal challenges…. Read more
Jeff Aronin, Chairman and CEO of Paragon Biosciences, has spent more than two decades in one of the most challenging areas of the biosciences sector. He and his teams have worked to find treatments for… Read more
CHICAGO–(BUSINESS WIRE)–May 13, 2019– Paragon Biosciences, LLC Chairman and CEO Jeff Aronin was recently recognized by the Northern Illinois University (NIU) College of Business as the 2019 recipient of their Innovation and Entrepreneurship Award. This press release… Read more
Paragon Biosciences is a life science innovator that invests in, builds, and advises bioscience companies. Their mission is to serve patients living with severe medical conditions which do not yet have adequate treatments. Watch the… Read more
CHICAGO–(BUSINESS WIRE)–Paragon Biosciences Chairman and CEO Jeffrey S. Aronin won a 2019 BIG Innovation Award presented by the Business Intelligence Group. The award honors executives whose leadership improves quality of life. Read the full article… Read more
As Chairman and CEO of Paragon Biosciences, Jeffrey Aronin has invested in and launched several successful portfolio companies, including: Harmony Biosciences, Castle Creek Pharma, Emalex Biosciences, and Skyline Biosciences. Previously, Mr. Aronin served as President and CEO of… Read more